Besides BC, CHEK2 pathogenic variants have been linked to various tumor types, including colorectal cancer, prostate cancer [90], renal cell carcinoma [91], thyroid cancer [92], testicular germ cell tumors [93], and male breast cancer [94]. This evidence concerns the gene CHEK2 and neoplasm.